期刊文献+

术前超声参数与甲状腺乳头状癌颈部淋巴结转移风险的相关性 被引量:2

Correlation between preoperative ultrasound parameters and the risk of cervical lymph node metastasis in papillary thyroid cancer
下载PDF
导出
摘要 目的探讨术前超声参数与甲状腺乳头状癌(papillary thyroid carcinoma,PTC)颈部淋巴结转移风险间的关系,为临床治疗决策的拟定及预后评估提供依据。方法选择2021年6月—2022年6月湖州市中心医院接受手术治疗的PTC患者148例为研究对象,根据颈部淋巴结转移情况分为转移组(59例)和非转移组(89例)。对比2组患者一般资料,术前常规超声参数(肿瘤最大径、边界、形态、距被膜距离等),采用Pearson相关性分析PTC超声声像图特征与颈部淋巴结转移的关系;采用多因素logistic回归分析研究PTC颈部淋巴结转移的影响因素。结果转移组微钙化、距被膜距离<1 mm、肿瘤最大径>7 mm占比较非转移组多(P<0.05);Pearson相关性分析显示,颈部淋巴结转移与微钙化(r=0.227,P<0.05)、距被膜距离(r=0.293,P<0.05)、肿瘤最大径(r=0.360,P<0.05)呈正相关关系;多因素logistic回归分析显示:微钙化(OR=2.601,95%CI:1.049~6.452)、距被膜距离<1 mm(OR=2.955,95%CI:1.102~7.922)、肿瘤最大径>7 mm(OR=2.965,95%CI:1.095~8.031)为PTC颈部淋巴结转移的危险因素(均P<0.05)。结论微钙化的出现、距被膜距离<1 mm、肿瘤最大径>7 mm超声参数提示PTC可能存在颈部淋巴结转移风险。 Objective To investigate the relationship between preoperative ultrasonography parameters and the risk of cervical lymph node metastasis in papillary thyroid carcinoma(PTC),in order to provide evidence for clinical treatment and prognosis evaluation.Methods A total of 148 patients with PTC who received surgical treatment in Huzhou Central Hospital from June 2021 to June 2022 were selected as subjects,and were divided into metastatic group(59 cases)and non-metastatic group(89 cases)according to cervical lymph node metastasis.The general data and preoperative conventional ultrasound parameters(tumor maximum diameter,boundary,morphology,distance from capsule,etc.)were compared between the two groups.Pearson correlation was used to analyze the correlation between PTC ultrasound image features and cervical lymph node metastasis.Multivariate logistic regression was used to analyze the influencing factors of cervical lymph node metastasis of PTC.Results The micro-calcification,distance from the capsule<1 mm,and the maximum diameter of the tumor>7 mm in the metastatic group were more than those in the non-metastatic group(P<0.05).Pearson correlation analysis showed that cervical lymph node metastasis was positively correlated with micro-calcification(r=0.227,P<0.05),distance from capsule(r=0.293,P<0.05),and maximum tumor diameter(r=0.360,P<0.05).Multivariate logistic regression analysis showed that micro-calcification(OR=2.601,95%CI:1.049-6.452),distance from capsule<1 mm(OR=2.955,95%CI:1.102-7.922),and the largest tumor diameter>7 mm(OR=2.965,95%CI:1.095-8.031)were risk factors for cervical lymph node metastasis in PTC(all P<0.05).Conclusion The appearance of micro-calcification,distance from the capsule<1 mm,and maximum diameter of the tumor>7 mm suggest that PTC may have the risk of cervical lymph node metastasis.
作者 李丹 吴万波 沈思平 姚黎丽 杨骏宇 阳建军 LI Dan;WU Wanbo;SHEN Siping;YAO Lili;YANG Junyu;YANG Jianjun(Department of Ultrasound,Huzhou Central Hospital,Huzhou,Zhejiang 313000,China)
出处 《中华全科医学》 2023年第6期1008-1011,共4页 Chinese Journal of General Practice
基金 浙江省医药卫生科技计划项目(2021KY1090)。
关键词 超声参数 甲状腺乳头状癌 颈部淋巴结转移 相关性 Ultrasound parameters Papillary thyroid carcinoma Cervical lymph node metastasis Correlation
  • 相关文献

参考文献2

二级参考文献56

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 3Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 4Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 5De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 6Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 7Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 8Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 9Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.
  • 10Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of NO papillary thyroid carcinoma[J]. Endocr J, 2013, 60 (1):113-117.

共引文献396

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部